Short-term outcomes following gastrectomy for adenocarcinoma: Assessing the role of social determinants of health.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 3/4)
유사 논문P · Population 대상 환자/모집단
341 patients, the median age was 66 years and 68.
I · Intervention 중재 / 시술
gastrectomy were identified in the National Cancer Database
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Mortality was less likely among Asian than White patients (OR = 0.60; 95 %CI:0.42-0.87). [CONCLUSION] Improving education and anticipating postoperative needs may lead to less disparate outcomes.
[BACKGROUND] It is unclear how social determinants of health (SDoH) impact short-term outcomes following gastrectomy for adenocarcinoma.
- 95% CI 0.69-0.82
APA
Moten AS, Bailey C, et al. (2026). Short-term outcomes following gastrectomy for adenocarcinoma: Assessing the role of social determinants of health.. American journal of surgery, 251, 116698. https://doi.org/10.1016/j.amjsurg.2025.116698
MLA
Moten AS, et al.. "Short-term outcomes following gastrectomy for adenocarcinoma: Assessing the role of social determinants of health.." American journal of surgery, vol. 251, 2026, pp. 116698.
PMID
41197204 ↗
Abstract 한글 요약
[BACKGROUND] It is unclear how social determinants of health (SDoH) impact short-term outcomes following gastrectomy for adenocarcinoma.
[METHODS] Patients with stages I-III gastric adenocarcinoma who underwent gastrectomy were identified in the National Cancer Database. Adjusted regression analyses identified SDoH (race, insurance, income, education) associated with length of stay (LOS), 30-day readmission, and 30-day mortality.
[RESULTS] Among 22,341 patients, the median age was 66 years and 68.5 % were White. Extended LOS was less likely among Black (OR = 0.75; 95 %CI:0.69-0.82), Hispanic (OR = 0.71; 95 %CI:0.65-0.79), and Asian patients (OR = 0.50; 95 %CI:0.45-0.56) compared to White patients, and less likely among patients from high-income rather than low-income regions (OR = 0.76; 95 %CI:0.69-0.85). Both extended LOS (OR = 1.19; 95 %CI:1.06-1.33) and readmission (OR = 1.26; 95 %CI:1.07-1.49) were more likely among patients with higher rather than lower regional education levels. Mortality was less likely among Asian than White patients (OR = 0.60; 95 %CI:0.42-0.87).
[CONCLUSION] Improving education and anticipating postoperative needs may lead to less disparate outcomes.
[METHODS] Patients with stages I-III gastric adenocarcinoma who underwent gastrectomy were identified in the National Cancer Database. Adjusted regression analyses identified SDoH (race, insurance, income, education) associated with length of stay (LOS), 30-day readmission, and 30-day mortality.
[RESULTS] Among 22,341 patients, the median age was 66 years and 68.5 % were White. Extended LOS was less likely among Black (OR = 0.75; 95 %CI:0.69-0.82), Hispanic (OR = 0.71; 95 %CI:0.65-0.79), and Asian patients (OR = 0.50; 95 %CI:0.45-0.56) compared to White patients, and less likely among patients from high-income rather than low-income regions (OR = 0.76; 95 %CI:0.69-0.85). Both extended LOS (OR = 1.19; 95 %CI:1.06-1.33) and readmission (OR = 1.26; 95 %CI:1.07-1.49) were more likely among patients with higher rather than lower regional education levels. Mortality was less likely among Asian than White patients (OR = 0.60; 95 %CI:0.42-0.87).
[CONCLUSION] Improving education and anticipating postoperative needs may lead to less disparate outcomes.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.